fbpx
September 14, 2020

Bedtime Virtual Reality Intervention May Improve Teens’ Sleep Bedtime Virtual Reality Intervention May Improve Teens’ Sleep

The combination of immersive virtual reality (VR) and slow breathing techniques helps promote bedtime relaxation and improves overall sleep quality in adolescents with and those without […]
September 14, 2020

High Plasma GFAP Level Predicts Disability in Progressive MS High Plasma GFAP Level Predicts Disability in Progressive MS

A high level of glial fibrillary acidic protein (GFAP) in the blood may predict worsening disability in patients with secondary progressive multiple sclerosis (MS), according to […]
September 13, 2020

Masitinib Impresses in ‘Nonactive’ Progressive MS Masitinib Impresses in ‘Nonactive’ Progressive MS

The investigational drug, masitinib (AB Science), which has a completely new mechanism of action for multiple sclerosis (MS), has shown a positive result in slowing disability […]
September 13, 2020

Multiple Sclerosis Prodrome Holds Promise of Earlier Diagnosis Multiple Sclerosis Prodrome Holds Promise of Earlier Diagnosis

“It is time that the prodromal phase of multiple sclerosis is formally recognized.” That was the conclusion of Helen Tremlett, PhD, delivering the opening plenary session […]
September 12, 2020

NfL Blood Biomarker Captures Suboptimal Treatment Response in MS NfL Blood Biomarker Captures Suboptimal Treatment Response in MS

Measuring serum levels of neurofilament light chain (NfL) is an effective way of detecting disease activity and the need to optimize treatment in patients with multiple […]
September 12, 2020

App for MS Aims to Capture Elusive Signals of Progression App for MS Aims to Capture Elusive Signals of Progression

Investigators in Switzerland are testing an application for smartphones that they hope will elucidate subtle signs of disease progression in multiple sclerosis (MS)—beyond what standard imaging […]
September 12, 2020

Lessons for Patients With MS and COVID-19 Lessons for Patients With MS and COVID-19

Two important lessons about managing patients with multiple sclerosis (MS) and COVID-19 have emerged from a hospital clinic in Madrid that managed COVID-infected patients with MS […]
September 12, 2020

Satralizumab Reduces Risk of Severe NMOSD Relapse Satralizumab Reduces Risk of Severe NMOSD Relapse

Compared with placebo, satralizumab reduces the risk of severe relapse in patients with neuromyelitis optica spectrum disorder (NMOSD), according to investigators. The drug also was associated […]
September 12, 2020

Exposure to DMT May Delay Disability Accumulation in Primary Progressive MS Exposure to DMT May Delay Disability Accumulation in Primary Progressive MS

For patients with primary progressive multiple sclerosis (MS), longer exposure to disease-modifying therapy (DMT) may delay the time at which a patient is restricted to a […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0